Ivermectin: a complimentary weapon against the spread of malaria?

References

• Watts G. Nobel awarded to discoverers of ivermectin and artemisinin. Bmj. 2015;351:5352.
   Web of Science ®Google Scholar
• Wilson ML. Avermectins in arthropod vector management - prospects and pitfalls. Parasitol Today. 1993;9(3):83–87.
   PubMedGoogle Scholar
• Kane NS, Hirschberg B, Qian S, et al. Drug-resistant drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci. 2000;97(25):13949–13954.
   PubMed Web of Science ®Google Scholar
• Buckingham S, Biggin P, Sattelle B, et al. Insect GABA receptors: splicing, editing, and targeting by antiparasitics and insecticides. Mol Pharmacol. 2005;68(4):942–951.
   PubMed Web of Science ®Google Scholar
• Õmura S, Crump A, Omura S, et al. Timeline: the life and times of ivermectin — a success story. Nat Rev Microbiol. 2004;2(12):984–989.
   PubMed Web of Science ®Google Scholar
• CDC. Progress toward elimination of onchocerciasis in the Americas - 1993-2012. Mmwr. 2013;62(20):405–408.
   PubMed Web of Science ®Google Scholar
• Rebollo MP, Bockarie MJ. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. Expert Rev Anti Infect Ther. 2013;11(7):723–731.
   PubMed Web of Science ®Google Scholar
• Pampiglione S, Majori G, Petrangeli G, et al. Avermectins, mk-933 and mk-936, for mosquito control. Trans R Soc Trop Med Hyg. 1985;79(6):797–799.
   PubMed Web of Science ®Google Scholar
• Foy BD, Kobylinski KC, Da Silva IM, et al. Endectocides for malaria control. Trends Parasitol. 2011;27(10):423–428.
   PubMed Web of Science ®Google Scholar
• Chaccour CJ, Kobylinski KC, Bassat Q, et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J. 2013;12(1):153.
   PubMed Web of Science ®Google Scholar
• Elkassaby MH. Ivermectin uptake and distribution in the plasma and tissue of sudanese and mexican patients infected with Onchocerca volvulus. Trop Med Parasitol. 1991;42(2):79–81.
   PubMedGoogle Scholar
• Ouédraogo AL, Bastiaens GJH, Tiono AB, et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis. 2015;60(3):357–365.
   PubMed Web of Science ®Google Scholar
• Bockarie MJ, Hii JLK, Alexander NDE, et al. Mass treatment with ivermectin for filariasis control in papua new guinea: impact on mosquito survival. Med Vet Entomol. 1999;13(2):120–123.
   PubMed Web of Science ®Google Scholar
• Sylla M, Kobylinski KC, Gray M, et al. Mass drug administration of ivermectin in south-eastern senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar J. 2010;9(1):365.
   PubMed Web of Science ®Google Scholar
• Alout H, Krajacich BJ, Meyers JI, et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments. Malar J. 2014;13(1):417.
   PubMed Web of Science ®Google Scholar
• Fritz ML, Siegert PY, Walker ED, et al. Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l. Ann Trop Med Parasitol. 2009;103(6):539–547.
   PubMed Web of Science ®Google Scholar
• Pooda HS, Rayaisse J-B, Hien DF De S, et al. Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria. Malar J. 2015;14(1):496.
   Web of Science ®Google Scholar
• Rosenberg R. Malaria: some considerations regarding parasite productivity. Trends Parasitol. 2008 Nov;24(11):487-491.
   PubMed Web of Science ®Google Scholar
• Koella JC. On the use of mathematical models of malaria transmission. Acta Trop. 1991;49(1):1–25.
   PubMed Web of Science ®Google Scholar
• Slater HC, Walker PGT, Bousema T, et al. The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. J Infect Dis. 2014;210(12):1972–1980.
   PubMed Web of Science ®Google Scholar
• Mueller I, Schoepflin S, Smith TA, et al. Force of infection is key to understanding the epidemiology of plasmodium falciparum malaria in papua new guinean children. Proc Natl Acad Sci. 2012;109(25):10030–10035.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526(7572):207–211.
   PubMed Web of Science ®Google Scholar
• Kobylinski KC, Alout H, Foy BD, et al. Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control. Am J Trop Med Hyg. 2014;91(4):655–662.
   PubMed Web of Science ®Google Scholar
• Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J. 2014;13:330.
   PubMed Web of Science ®Google Scholar
• Hooper PJ, Zoerhoff KL, Kyelem D, et al. Short report: the effects of integration on financing and coverage of neglected tropical disease programs. Am J Trop Med Hyg. 2013;89(3):407–410.
   PubMed Web of Science ®Google Scholar
• Cano J, Rebollo MP, Golding N, et al. The global distribution and transmission limits of lymphatic filariasis: past and present. Parasites and Vectors. 2014;7(1):466.
   PubMed Web of Science ®Google Scholar
• Brooker S. Epidemiology of plasmodium-helminth co-infections in Africa: population risk, potential impact on anaemia and prospects for combining control. Am J Trop Med Hyg. 2007;77(Suppl 6):88–98.
   PubMed Web of Science ®Google Scholar
• Raviglione MC, Uplekar MW. WHO’s new stop tb strategy. Lancet. 2006;367(9514):952–955.
   PubMed Web of Science ®Google Scholar
• Duke BO, Zea-Flores G, Castro J, et al. Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg. 1991;45(1):132–137.
   PubMed Web of Science ®Google Scholar
• Torres JR, Isturiz R, Murillo J, et al. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis. 1993;17(5):900–902.
   PubMed Web of Science ®Google Scholar
• Awadzi K, Opoku NO, Addy ET, et al. The chemotherapy of onchocerciasis. the clinical and laboratory tolerance of high-dose ivermectin. Trop Med Parasitol. 1995;46(2):131–137.
   PubMedGoogle Scholar
• Kamgno J, Gardon J, Gardon-Wendel N, et al. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly. Trans R Soc Trop Med Hyg. 2004;98(8):496–504.
   PubMed Web of Science ®Google Scholar
• Guzzo CA, Furtek CI, Porras AG, et al. Safety, tolerability and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol. 2002;42(10):1122–1133.
   PubMed Web of Science ®Google Scholar
• Chaccour C, et al. Screening for an ivermectin slow-release formulation suitable for malaria vector control. Malar J. 2015;14:102.
   PubMed Web of Science ®Google Scholar
• Plaisier AP, Stolk WA, Van Oortmarssen GJ, et al. Effectiveness of annual ivermectin treatment for wuchereria bancrofti infection. Parasitol Today. 2000;16(7):298–302.
   PubMedGoogle Scholar
• Sodahlon YK, Dorkenoo AM, Morgah K, et al. A success story: togo is moving toward becoming the first sub-saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation. Plos Negl Trop Dis. 2013;7(4):e2080.
   PubMed Web of Science ®Google Scholar
• Da Cruz FP, Martin C, Buchholz K, et al. Drug screen targeted at plasmodium liver stages identifies a potent multistage antimalarial drug. J Infect Dis. 2012;205(8):1278–1286.
   PubMed Web of Science ®Google Scholar
• Mendes A.M., et al. Inhibition of Plasmodium liver infection by ivermectin. Antimicrob Agents Chemother. 2016.
   Google Scholar
• Panchal M, Rawat K, Kumar G, et al. Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP. Cell Death Dis. 2014;5:e994.
   PubMed Web of Science ®Google Scholar
• Nasveld P, Russell B, Kotecka B, et al. Lack of in vitro effect of ivermectin on plasmodium falciparum. Southeast Asian J Trop Med Public Health. 2003;34(3):552–553.
   PubMedGoogle Scholar
• Lariviere M, Beauvais B, Aziz M, et al. [A study in the ivory coast (1985-1987) of the efficacy and tolerance of ivermectin (mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]. Bull Soc Pathol Exot Filiales. 1989;82(1):35–47.
   PubMed Web of Science ®Google Scholar
• Kobylinski KC, Foy BD, Richardson JH. Ivermectin inhibits the sporogony of plasmodium falciparum in Anopheles gambiae. Malar J. 2012;11:381.
   PubMed Web of Science ®Google Scholar
• Lambrechts L, Halbert J, Durand P, et al. Host genotype by parasite genotype interactions underlying the resistance of anopheline mosquitoes to. Plasmodium Falciparum Insect Mol Biol. 2005;4:3.
   Google Scholar
• Cohuet A, Osta MA, Morlais I, et al. Anopheles and plasmodium: from laboratory models to natural systems in the field. EMBO Rep. 2006;7(12):1285–1289.
   PubMed Web of Science ®Google Scholar
• Harris C, Morlais I, Churcher TS, et al. Plasmodium falciparum produce lower infection intensities in local versus foreign Anopheles gambiae populations. Plos One. 2012;7:(1), e30849.
   Web of Science ®Google Scholar
• Coccini T, Candura SM, Manzo L, et al. Interaction of the neurotoxic pesticides ivermectin and lindane with the enteric GABA A receptor-ionophore complex in the guinea-pig. Eur J Pharmacol Environ Toxicol. 1993;248(1):1–6.
   PubMed Web of Science ®Google Scholar
• Tonini M, Costa LG, Candura SM, et al. Interaction of the pyrethroid insecticides tetramethrin and cypermethrin with enteric cholinergic transmission in the guinea-pig. Neurotoxicology. 1989;10(4):707–715.
   PubMed Web of Science ®Google Scholar
• Sreeramulu K, Liu R, Sharom FJ. Interaction of insecticides with mammalian P-glycoprotein and their effect on its transport function. Biochim Biophys Acta. 2007;1768:1750–1757.
   PubMed Web of Science ®Google Scholar
• Podsiadlowski L, Matha V, Vilcinskas A. Detection of a P-glycoprotein related pump in chironomus larvae and its inhibition by verapamil and cyclosporin A. Comp Biochem Physiol Part B Biochem Mol Biol. 1998;121(4):443–450.
   PubMed Web of Science ®Google Scholar
• Lecoeur S, Videmann B, Mazallon M. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Toxicol Lett. 2006;161(3):200–209.
   PubMed Web of Science ®Google Scholar
• Agarwala S, Chen W, Cook TJ. Effect of chlorpyrifos on efflux transporter gene expression and function in caco-2 cells. Toxico Vitr. 2004;18(4):403–409.
   PubMed Web of Science ®Google Scholar
• Shabbir A, DiStasio S, Zhao J, et al. Differential effects of the organochlorine pesticide DDT and its metabolite p,p′-DDE on p-glycoprotein activity and expression. Toxicol Appl Pharmacol. 2005;203(2):91–98.
   PubMed Web of Science ®Google Scholar
• Griffin J, Fletcher N, Clemence R, et al. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. J Vet Pharmacol Ther. 2005;28(3):257–265.
   PubMed Web of Science ®Google Scholar
• Bain LJ, LeBlanc GA. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol Appl Pharmacol. 1996;141(1):288–298.
   PubMed Web of Science ®Google Scholar
• Buss DS, McCaffery AR, Callaghan A. Evidence for p-glycoprotein modification of insecticide toxicity in mosquitoes of the Culex pipiens complex. Med Vet Entomol. 2002;16:218–222.
   PubMed Web of Science ®Google Scholar
• Yoon KS, Strycharz JP, Baek JH, et al. Brief exposures of human body lice to sublethal amounts of ivermectin over-transcribes detoxification genes involved in tolerance. Insect Mol Biol. 2011;20(6):687–699.
   PubMed Web of Science ®Google Scholar
• Deus KM, Saavedra-Rodriguez K, Butters MP, et al. The effect of ivermectin in seven strains of Aedes aegypti (diptera : culicidae) including a genetically diverse laboratory strain and three permethrin resistant strains. J Med Entomol. 2012;49(2):356–363.
   PubMed Web of Science ®Google Scholar
• Martinez-Torres D, Chandre F, Williamson MS, et al. Molecular characterization of pyrethroid knockdown resistance (kdr) in the major malaria vector Anopheles gambiae s.s. Insect Mol Biol. 1998;7(2):179–184.
   PubMed Web of Science ®Google Scholar
• Blackhall WJ, Liu HY, Xu M, et al. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of haemonchus contortus. Mol Biochem Parasitol. 1998;95(2):193–201.
   PubMed Web of Science ®Google Scholar
• Njue AI, Prichard RK. Genetic variability of glutamate-gated chloride channel genes in ivermectin-susceptible and -resistant strains of cooperia oncophora. Parasitology. 2004;129(6):741–751.
   PubMed Web of Science ®Google Scholar
• Geerts S, Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev. 2000;13(2):207–222.
   PubMed Web of Science ®Google Scholar
• Currie BJ, Harumal P, McKinnon M, et al. First documentation of in vivo and in vitro ivermectin resistance in sarcoptes scabiei. Clin Infect Dis. 2004;39(1):8–12.
   PubMed Web of Science ®Google Scholar
• Osei-Atweneboana MY, Awadzi K, Attah SK, et al. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. Plos Negl Trop Dis. 2011;5(3):e998.
   PubMed Web of Science ®Google Scholar
• Thomsen EK, Sanuku N, Baea M, et al. Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of bancroftian filariasis. Clin Infect Dis. 2016;62(3):334–341.
   PubMed Web of Science ®Google Scholar
• Kobylinski KC, Deus KM, Butters MP, et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop. 2010;116(2):119–126.
   PubMed Web of Science ®Google Scholar
• Kaplan RM, Vidyashankar AN. An inconvenient truth: global worming and anthelmintic resistance. Vet Parasitol. 2012;186(1–2):70–78.
   PubMed Web of Science ®Google Scholar
• Seaman JA, Alout H, Meyers JI, et al. Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals. BMC Genomics. 2015;16(1):797.
   PubMed Web of Science ®Google Scholar
• Scott TW, et al. DNA profiling of human blood in anophelines from lowland and highland sites in Western Kenya. Am J Trop Med Hyg. 2006;75(2):231–237.
   PubMed Web of Science ®Google Scholar
• Stone W, Gonçalves BP, Bousema T, et al. Assessing the infectious reservoir of falciparum malaria: past and future. Trends Parasitol. 2015;31(7):287–296.
   PubMed Web of Science ®Google Scholar